Paul Schmidt
Keine laufenden Positionen mehr
Vermögen: 3 912 $ am 30.04.2024
Profil
Paul Schmidt served as the Chief Executive Officer & Executive Director at Plant Health Care Plc from 2015 to 2016.
Prior to that, he worked at Alberta Innovates BioSolutions as a Director.
Schmidt received his undergraduate and graduate degrees from the University of Saskatchewan in 1980.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PLANT HEALTH CARE PLC
0,02% | 01.03.2024 | 82 000 ( 0,02% ) | 3 912 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Paul Schmidt
Unternehmen | Position | Ende |
---|---|---|
PLANT HEALTH CARE PLC | Vorstandsvorsitzender | 30.11.2016 |
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Direktor/Vorstandsmitglied | - |
Ausbildung von Paul Schmidt
University of Saskatchewan | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PLANT HEALTH CARE PLC | Process Industries |
Private Unternehmen | 1 |
---|---|
Alberta Innovates BioSolutions
Alberta Innovates BioSolutions BiotechnologyHealth Technology Alberta Innovates BioSolutions develops bioindustrial technologies and natural products. It delivers on the potential of agriculture and forestry in areas such as: value chain sustainability, advancing the biorefinery, quality food for health, industry challenges and emerging opportunities, and prion and prion-like protein misfolding diseases. The firm aims to be a global gateway and resource for bio-based research, talent, investment and solutions. The company was founded on January 1, 2010 and is headquartered in Edmonton, Canada. | Health Technology |